Digital health company, ResApp Health
(ASX:RAP) has been selected to join the Startup Creasphere Digital Health Program in Munich.
The program is a health-focused accelerator. CEO and Managing Director, Tony Keating says they “are very excited to participate in the Startup Creasphere program to build and pilot a consumer health-focused product using [their] novel respiratory diagnostic algorithms”.
This 12 month collaboration with the consumer healthcare business unit of Sanofi should provide ResApp with an opportunity to explore the direct-to-consumer market alongside global industry leaders.
After the program neither ResApp nor Sanofi has committed to any obligations regarding any of the products created and ResApp retains all intellectual property developed under the program.
Shares in ResApp Health
(ASX:RAP) closed 1.82 per cent lower at 27 cents.
